ADIPOQ and myeloid sarcoma: Accordingly, it appears that the complex molecular regulatory network, comprising adiponectin and other molecular players involved in the regulation of lipoprotein metabolism, operates differently under physiological conditions than in the presence of insulin resistance, inflammation, and perturbed metabolism, the pathophysiological constellations encountered in MS.